ACOR

Acorda Therapeutics
ACOR

Overview Fund Trends Analyst Outlook Journalist POV
Delisted

ACOR was delisted on the 11th of April, 2024.

Back to rankings

34 hedge funds and large institutions have $18.1M invested in Acorda Therapeutics in 2021 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 6 increasing their positions, 12 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding

Funds holding: →

more capital invested

Capital invested by funds: $ → $

less call options, than puts

Call options by funds: $ | Put options by funds: $

50% less repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 12

Holders
34
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$749K
Puts
$893K
Net Calls
Net Calls Change

Top Buyers

1
+$937K
2
+$325K
3
+$235K
4
Citadel Advisors
Citadel Advisors
Florida
+$213K
5
State Street
State Street
Massachusetts
+$151K

Top Sellers

1
-$543K
2
-$478K
3
-$311K
4
QI
QS Investors
New York
-$247K
5
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$229K
Name Holding Trade Value Shares
Change 		Change in
Stake
26
$1K
27
$1K
28
–
29
–
30
–
31
–
32
–
1
2